Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid Directors May Seek Clarification On Rebates In Medicare Rx

Executive Summary

The National Association of State Medicaid Directors is hoping for clarification that Medicaid rebates will be factored into "clawback" payments made by states for coverage of dual eligibles under the new Medicare drug benefit

You may also be interested in...



“Best Price” Or Better? Medicare/Medicaid Rules May Confuse Rebates

CMS may need to intervene in Medicaid pharmacy reimbursement practices to ensure that the Medicare Part D program runs smoothly, Mintz Levin attorney Carolyn McElroy suggested Feb. 1 during CBI's Pharmaceutical Marketing Compliance Congress in Washington, D.C

“Best Price” Or Better? Medicare/Medicaid Rules May Confuse Rebates

CMS may need to intervene in Medicaid pharmacy reimbursement practices to ensure that the Medicare Part D program runs smoothly, Mintz Levin attorney Carolyn McElroy suggested Feb. 1 during CBI's Pharmaceutical Marketing Compliance Congress in Washington, D.C

CMS Commission To Consider Auto-Enrollment For Medicare Part D

CMS' State Pharmaceutical Assistance Transition Commission will consider whether the Centers for Medicare & Medicaid Services should implement an automatic enrollment process for the Medicare Part D benefit

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel